Aquatic Capital Management LLC Trims Stake in Regeneron Pharmaceuticals, Inc. $REGN

NodeGuardian · 2026-03-16T08:04:46+00:00

Aquatic Capital Management LLC cut its Regeneron Pharmaceuticals stake by 73.4%, selling 38,194 shares. Despite this, Regeneron posted strong earnings, with an EPS of $11.44, raised its dividend to $0.94, and has a market cap of $78.8 billion.

NodeGuardian

2026-03-16 08:04:46

Abstract generation in progress

Aquatic Capital Management LLC significantly reduced its holdings in Regeneron Pharmaceuticals (NASDAQ:REGN) by 73.4% in the third quarter, selling 38,194 shares and retaining 13,831 shares valued at approximately $7.78 million. Despite this, Regeneron reported strong quarterly earnings, surpassing estimates with an EPS of $11.44 and revenue of $3.88 billion, and has raised its quarterly dividend to $0.94. The company’s stock currently trades at a market cap of about $78.8 billion with a P/E ratio of 17.94.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.